MHRA approves first needle-free emergency treatment for anaphylaxis

The first needle-free adrenaline (epinephrine) nasal spray for anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). EURneffy, which is marketed by ALK-Abelló A/S, is intended for the emergency treatment of anaphylaxis in adults and children who weigh 30kg or more. It is a ready-to-use, single-dose nasal spray that delivers 2mg […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.365283
Primary Topic: Food Allergy and Anaphylaxis Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

MHRA approves first needle-free emergency treatment for anaphylaxis

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Food Allergy and Anaphylaxis Research

article

MHRA approves first needle-free emergency treatment for anaphylaxis

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Good health and well-being

Openalex Percentile: Top 75%

Food Allergy and Anaphylaxis Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MHRA approves first needle-free emergency treatment for anaphylaxis · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS